Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid diseaseLivius Penter, Catherine J. Wu, Yang Liu et al.|Blood|2023Cited by 51
Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I TrialEdwin R. Parra, Cara Haymaker, Sacha Gnjatic et al.|Clinical Cancer Research|2024Cited by 42
Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantationLivius Penter, Catherine J. Wu, Yi Zhang et al.|Blood|2021Cited by 42
Tutorial: integrative computational analysis of bulk RNA-sequencing data to characterize tumor immunity using RIMALin Yang, X. Shirley Liu, Jin Wang et al.|Nature Protocols|2023Cited by 21
Cross-Site Concordance Evaluation of Tumor DNA and RNA Sequencing Platforms for the CIMAC-CIDC NetworkZexian Zeng, Catherine J. Wu, Jingxin Fu et al.|Clinical Cancer Research|2020Cited by 15